You have 9 free searches left this month | for more free features.

Condition

Wet Age-related Macular Degeneration (2)

Nonproliferative Diabetic Retinopathy (1)

Overall Status

Not yet recruiting (2)

Completed (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

EyePoint Pharmaceuticals, Inc. (3)

Collaborator

Intervention

eyp-1901 (3)

aflibercept 2mg/0.05ml inj,oph (1)

sham ivt (1)

Study Documents

Intervention Type

drug (3)

other (1)

Funder Type

Industry (3)

Study Type

Interventional (3)

eyp-1901

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Nonproliferative Diabetic Retinopathy Trial (EYP-1901, Sham IVT)

Not yet recruiting

Nonproliferative Diabetic Retinopathy

EYP-1901
Sham IVT

(no location specified)

Aug 3, 2022

Wet Age-related Macular Degeneration Trial in United States (Eyp-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)

Not yet recruiting

Wet Age-related Macular Degeneration

Eyp-1901
Aflibercept 2Mg/0.05Ml Inj,Oph

(no location specified)

Jul 25, 2022

Wet Age-related Macular Degeneration Trial in United States (EYP-1901)

Completed

Wet Age-related Macular Degeneration

EYP-1901

Phoenix, Arizona
+10 more

Jul 25, 2022